KR20090030441A - Food composition for reducing abdominal obesity containing dietary fiber and fructooligosaccharide - Google Patents

Abstract

A food composition containing dietary fiber and fructooligosaccharide for reducing abdominal obesity is provided to give satiety, to promotes the evacuation and to take the food composition without side effects for a long term. A food composition for reducing abdominal obesity contains inulin and fructooligosaccharide. The food composition for reducing abdominal obesity further contains glucomannan and red wine extracts. Particularly, the food composition for reducing abdominal obesity comprises inulin 3-25 g, the fructo-oligosaccharide 0.5-10 g, and the red wine extracts 0.01-2 g and glucomannan 0.1-5 g based on the dry weight.

Description

Food composition for reducing abdominal obesity containing dietary fiber and fructooligosaccharides

The present invention relates to a food composition containing natural dietary fiber and fructooligosaccharide to induce abdominal obesity by promoting bowel activity while increasing satiety. More specifically, the present invention relates to a food composition having an excellent effect on enhancing satiety, promoting bowel movements, and reducing abdominal obesity by containing inulin and fructooligosaccharides, which are dietary fibers as main ingredients, and glucomannan and red wine extracts as auxiliary ingredients.

Abdominal obesity easily occurs when the basic metabolic rate is lowered due to poor diet, modest lifestyles, excessive stress, and lack of exercise. Clinically, obesity is measured by the waist / hip ratio. In the case of men, W / H ratio is classified as abdominal obesity when 0.9 or more. For women, 0.85 is the standard. Males are basically 2-3 times more visceral than females, and they are more likely to drink, smoke, and consume high-fat foods, and women are more likely to develop postmenopausal follicular atresia. Estrogen synthesis and secretion are reduced due to ovarian dysfunction, and various diseases can be caused by elevated levels of gonadotropins secreted from the pituitary gland (Choi Y, Yoon et al. Korean J. Nutr. 34 ( 3): 322-329,2001). Especially in postmenopausal women, abdominal adipose tissue increases due to female hormone deficiency and various causes (Turcato E. et al. J Intern Med 241 (5): 363-372,1997). Before menopause, the effects of female hormones on cardiovascular disease occur in only 1/4 to 1/5 of men, but after menopause, estrogen, a female hormone, is shortened, leading to a rapid increase in the incidence of cardiovascular disease. It is until.

Over the last 40 years, there has been a continuous study of the mechanisms for suppressing hunger by increasing satiety, which is the most effective way to control diet. In this study, a method of prolonging gastric emptying sensation due to gastric intestinal swelling and delayed food movement time using insoluble carbohydrates, and the satiety center of the hypothalamus (VMH), more specifically the secretion of Cholecystokinin (CCK) The method of suppressing appetite through stimulation is most widely known. In this regard, US Pat. No. 4,491,578 discloses oral administration of trypsin inhibitors that increase satiety by stimulating the release of cholecystokinin and US Pat. No. 6,207,638 nutritionally promotes and prolongs the state of satiety by stimulating the release of CCK. Disclosed is a coherent composition. However, the abdominal obesity reduction mechanism of the composition relates to limiting calorie intake by simply giving satiety without considering overall nutritional requirements.

Therefore, it is possible to induce abdominal obesity through the promotion of bowel movements as well as to improve satiety, and to facilitate the prevention of abdominal obesity, and to help prevent and reduce abdominal obesity. It became.

Therefore, the present inventors use a dietary fiber and fructooligosaccharide, which have been recognized for its safety and effectiveness, and add foods for improving satiety, promoting bowel movements, and adding fat-assisted ingredients to improve abdominal obesity improvement effect. As a result of efforts to develop functional foods, food composition containing dietary fiber, inulin, fructooligosaccharide, glucomannan, and red wine extract, gives a feeling of satiety and promotes bowel activity, and is effective in reducing abdominal obesity. The discovery of no side effects has led to the completion of the present invention.

Therefore, it is an object of the present invention to improve the abdominal obesity improvement effect by containing dietary fiber and fructooligosaccharide as a main component, and to provide a safe food composition even in the long-term intake.

In order to achieve the above object, the present invention provides a food composition for reducing abdominal obesity containing inulin and fructooligosaccharide.

In addition, the food composition may further contain red wine extract and glucomannan.

The food composition imparts satiety and promotes bowel movements to reduce abdominal obesity.

The present invention is effective in inducing bowel activity and inducing abdominal obesity by providing a feeling of satiety by containing inulin, fructooligosaccharide, glucomannan and red wine extracts, which are dietary fibers, and can be consumed for a long time without side effects. In addition, it is possible to obtain an abdominal obesity reduction effect only by additionally ingesting the composition of the present invention while maintaining the same life as usual.

The food composition of the present invention contains inulin and fructooligosaccharide as main components, and red wine extract and glucomannan as auxiliary components.

Hereinafter, the present invention will be described in more detail.

One component of the composition of the present invention is inulin, which is a water soluble fiber. Inulin is a polysaccharide that is widely distributed in the natural world and is present in the form of a colloid in chunks of chrysanthemum plants such as dahlia, pork potato, elecapane, and roots of chicory. . Unlike starch, it dissolves in hot water, and its structure consists of a structure formed by dehydration of D-fractose by the β- (2 → 1) bond on the fructose side of sucrose. . Plant-derived inulin is somewhat different, but has an average molecular weight of 2282-17000. Inulin is not only an indigestible dietary fiber but is also involved in improving the intestinal environment due to the proliferative effect of the intestinal beneficial bacterium, Bifidus, and in promoting the secretion of GLP-1 (Glucagon-Like Peptide-1), which is released from the intestine. It is also known to affect intake.

The content of the inulin is preferably 3 to 25 wt.g in dry weight based on a single intake dose, and more preferably 3 to 15 wt.g in consideration of health functional food. If it is less than 3g by weight can not exhibit the same effect as above, if it is more than 25g by weight can not be expected to increase the effect of increasing the content.

Another component in the composition of the present invention is fructooligosaccharide. Fructooligosaccharide is β- (2,1) -binding of 1 to 3 molecules of fructose (sucrose) to sucrose, 1-ketose (1-ketose GF2), Nystose GF3 and fructosyl Oligosaccharide consisting of nythose (Fructosyl nystose GF4) is widely distributed in asparagus, onion, pork potato, chicory. Fructooligosaccharides are low-calorie and have been shown to have functional properties such as growth factors of lactic acid bacteria and bifidus bacteria, improvement of intestinal flora, inhibition of harmful bacteria growth, improvement of bowel quality, and immunity enhancement. Some fructooligosaccharides increase calcium absorption enhancement effects. According to U.S. Patent No. 5,827,526, ingestion of 0.5-5 g of fructooligosaccharides per day has the effect of inhibiting diarrhea, and Korean Patent Publication No. 2000-57520 discloses a mixture of fructooligosaccharides and galactooligosaccharides. In this case, the intestinal flow is improved to a favorable state, and a formal effect is expressed, and positive results have been obtained for bowel movements.

The content of fructooligosaccharide is preferably 0.5 to 10 g by weight in dry weight based on a single intake dose. When ingested at the same time as the main ingredient composition inulin, more preferably less than 0.5 to 5g by weight is most preferred. If the amount is less than 0.5g, the above effects may not be exhibited. If the amount is less than 10g, it may cause specific side effects such as diarrhea and bloat.

Another component of the composition of the present invention is a red wine extract. Red wine extract removes 85% of the water that constitutes red wine and contains alcohol, vitamins, sugars, organic acids, various minerals and polyphenols. In particular, the polyphenols contained in wine act as antioxidants to remove free radicals, inhibit cholesterol oxidation, and have a strong anti-cancer substance known as quercetin, as well as an enzyme called PST-P that removes bacteria and plays a role in detoxification. In addition, lactic acid bacteria and glycerin contained in red wine are good for indigestion and constipation, and glucose and fructose help promote digestive absorption of the intestine.

The red wine extract is preferably 0.01 to 2 g by weight, more preferably 0.01 to 0.5 g by weight based on a single intake dose. This is because when less than 0.01% by weight can not exhibit the same effect, when contained in more than 2% by weight because the taste and aroma of the red wine can act largely in the sensual part.

Another component in the composition of the present invention is glutmannan (aka konjac mannan), which is a component that directly affects the feeling of late satiety. Glucomannan is a hypotonic polysaccharide obtained by purifying konjac. It is a digestive polysaccharide in which sugar disaccharide is combined, consisting of 1 molecule of glucose and 2 molecules of mannose and containing 1: 2 of glucose and mannose. It is a polymer compound with a molecular weight of about 1 million, and becomes a viscous grass form by dissolving in water. Glucomannan swells by absorbing water from the stomach in the first step, and gelatinization begins by enclosing fat in the colloidal state in the duodenum in the second step, and absorbs water from the small intestine and mixes it with stool in the third step. It is still semi-fluid at this stage. In 4 stages, water is absorbed from the large intestine and gelatinization proceeds. In 5 stages, colonization is performed in the colon to form a stool form. In addition, glucomannan starts to swell 5 minutes after ingestion by water, and after 6 hours, the swelling property is 200 times larger than the initial intake.

The content of the glucomannan is most effective when the amount is 0.1 to 5 g by dry weight based on a single intake dose. This is because when it is less than 0.1 wt g, the above effects cannot be exhibited, and when it is more than 5 wt g, it is not possible to expect the effect of increasing the content.

Therefore, in the present invention, by containing the inulin, fructooligosaccharide, red wine extract and glucomannan can be used for effective use in reducing abdominal obesity by promoting bowel activity while promoting early and late satiety.

The compositions of the present invention may optionally be formulated into dry powders, granules, capsules, tablets, pills, beverages, emulsion forms, diet bars, chocolates, caramel formulations, cereals or confectionary, etc., using other excipients and blending as appropriate. It can be used as health functional food and general food.

Hereinafter, the present invention will be described in more detail with reference to Examples and Experimental Examples. The following examples and experimental examples are merely illustrative of the present invention, but the content of the present invention is not limited thereto. In the following, the compounding amount is expressed in weight%.

In Experimental Examples 1 to 5 below, experiments were conducted on 18 women over 25 years old, and the average age of the test subjects was 35.8 years, weight 58.3 kg, and BMI = 25.7.

[Reference Example]

The powdery preparations of Examples 1 to 5 and Comparative Examples were prepared by weighing and mixing the raw materials as prescribed in Table 1 below.

Composition table of preparation (unit: weight%) ingredient Comparative example Example 1 Example 2 Example 3 Example 4 Example 5 Starch 94.83 12.50 3.50 9.50 0.50 - Inulin - 82.33 82.33 82.33 82.33 82.33 Fructooligosaccharide - - 9.00 - 9.00 9.00 Glucomannan - - - 3.00 3.00 3.00 Red Wine Extract - - - - - 0.50 Xylitol 3.50 3.50 3.50 3.50 3.50 3.50 Vitamin C 1.50 1.50 1.50 1.50 1.50 1.50 Synthetic flavor powder 0.15 0.15 0.15 0.15 0.15 0.15 Synthetic sweeteners 0.02 0.02 0.02 0.02 0.02 0.02

 Experimental Example 1 Satiety Evaluation of Inulin, Fructooligosaccharide, Glucomannan and Red Wine Extract

In order to measure the effects of inulin, fructooligosaccharide, glucomannan and red wine on satiety, the subjects limit their food intake after sleep to calculate satiety to zero before intake on an empty stomach, and consume it every 30 minutes after breakfast. The feeling of satiety at intervals was recorded in a questionnaire divided by 0 ± 10, which is a total of 20 levels. The composition prepared by converting the content% ratio of Table 1 in 7 wt g units was mixed with 120 ml of lukewarm water to be consumed within 5 minutes, and compared with the starch as a comparative example. The results are shown in Table 2 and FIG. 1.

Comparative example Example 1 Example 2 Example 3 Example 4 Example 5 30 minutes later 3.75 5.57 6.74 5.68 6.78 6.98 1 hour later 3.18 5.12 6.16 5.24 6.38 6.54 1 hour and 30 minutes later 2.33 4.36 5.53 4.83 5.78 5.97 2 hours later 1.48 3.26 4.32 4.43 4.98 5.35 2 hours and 30 minutes later 0.34 2.14 2.58 3.64 4.23 4.53 3 hours later 0.12 1.78 1.86 3.36 4.25 3.94

In the results of Table 2 and Figure 1, inulin and fructooligosaccharides were found to affect the initial satiety can be defined as 2 hours before ingestion, Glucomannan exhibited greater efficacy on late satiety Appeared to be. Therefore, it can be seen that inulin, fructooligosaccharide and glucomannan have a great effect on satiety, and red wine extract has no direct effect on satiety.

Experimental Example 2 Evaluation of Change Factors Associated with Bowel Activity

In order to evaluate the effect of the composition on the number of bowel movements and bowel movements after ingestion by using the composition of Example 5, the volunteers who participated in the experiment by preliminary investigation were to record the bowel state for 3 days while living as usual. Thereafter, when the intake of the composition of Example 5 for 7 days and 3 days after the end of ingestion was recorded, the results were as shown in Table 3.

3-day average before intake 7 days average intake 3 days average after ingestion Bowel movements per day 0.76 times / day 1.04 times / day 0.94 times / day Side 70.5% 92.8% 83.4% 1 Large Deflection ^* (Normal) 46.4% 95.2% 78.5% ^** form of ^stools (slightly softer) 42.9% 112.6% 90.2%

* One large defecation is divided into small, slightly less, normal, slightly more, and more.

** The shape of the side is divided into hard, slightly hard, normal, slightly soft and soft.

In the results of Table 3, the number of bowel movements per day was 0.76 times a day before ingestion, whereas the number of bowel movements increased by 36.8% from 1.04 times during ingestion, and 23.7% compared to 0.94 times before ingestion even after 3 days of intake. It can be seen that an increased result was obtained.

In the testimonial, the response to wanting to have a bowel movement, only 70.5% of volunteers felt the variance before ingestion, but during the intake, it increased by 22.8% to 92.8% and increased by 13.4% to 83.4% after the intake.

In the case of single stool, 46.4% of volunteers felt more than normal before ingestion, but it was increased by 48.8% and 32.1% to 95.2% during ingestion and 78.5% after ingestion, respectively.

42.9% of volunteers answered that the stool was slightly softer than before, while the intake increased by 112.6% to 2.5 times and 90.2% after the intake.

Experimental Example 3 Evaluation on Weight, Body Fat and Abdominal Obesity Reduction

Before and after the start of intake to evaluate the effects of satiety and bowel movement promotion on weight and body fat, BMI, body fat percentage (%), WHR, visceral fat area change after 8 weeks of ingestion using the composition of Example 5 Three days a week ± 5 days, 8 weeks ± 7 days after the start of intake measured by InBody 4.0 (Biospace, electric impedance utilization meter) is shown in Table 4 below. During the measurement, the same clothing should be worn on the day of measurement to reduce the deviation caused by clothing. To minimize the mechanical measurement error, all worn metals were measured after undressing.

N = 16 people Before intake 4 weeks after ingestion 8 weeks after ingestion Weight (kg) 58.2 ± 5.9 57.6 ± 5.6 56.4 ± 4.7 ^* BMI 25.2 ± 1.2 24.9 ± 1.1 24.8 ± 0.9 Body fat (kg) 22.3 ± 2.8 21.6 ± 3.2 21.1 ± 3.2 % Of body fat 34.5 ± 3.0 33.6 ± 3.2 ^* 33.2 ± 2.9 WHR 0.89 ± 0.06 0.87 ± 0.05 ^* 0.86 ± 0.07 ^* Visceral fat (㎠) 74.0 ± 25.3 72.5 ± 27.2 ^* 71.4 ± 28.5 ^*

The numerical values represent mean ± standard deviation.

* Indicates a significant difference after ingestion compared to before ingestion of t-test results (p <0.05)

BMI (Body Mass Index) = Body Mass Index = Body weight (kg) / height (㎡)

WHR: Waist-Hip Ratio

Visceral Fat Area (㎠)

Statistics were processed using Minitab, a statistical program, and 2 persons with less than 80% compliance with product intake were excluded from the statistical process.

As shown in the results of Table 4, the weight tended to decrease after 4 weeks of ingestion, but no significant difference appeared. The percentage of body fat (%) also showed a significant difference after 4 weeks of ingestion, and WHR and visceral fat, which are indicators of abdominal fat loss, also showed significant results to help improve bowel movements while giving satiety. It was found to express a direct effect on reducing body weight and abdominal obesity.

1 is a graph evaluating satiety of Examples 1 to 5 and Comparative Examples.

Claims (6)

A food composition for reducing abdominal obesity containing inulin and fructooligosaccharide. According to claim 1, wherein the composition for reducing abdominal obesity characterized in that it further comprises glucomannan and red wine extract. According to claim 1 or 2, wherein the inulin by weight based on a single intake dose of 3 to 25g, the fructooligosaccharides 0.5 to 10g, red wine extract 0.01 to 2g, glucomannan Food composition for reducing abdominal obesity, characterized in that it is contained in 0.1 to 5g by weight. The food composition of claim 1 or 2, wherein the food composition imparts satiety. The food composition of claim 1 or 2, wherein the food composition promotes bowel activity. According to claim 1 or 2, wherein the food composition is a dry powder, granules, capsules, tablets, pills, beverages, emulsion form, diet bar, chocolate, caramel formulation, cereal or confectionary formulations characterized in that Food composition.

Images